References
- Abbas, S., Lugthart, S., Kavelaars, F.G., Schelen, A., Koenders, J.E., Zeilemaker, A., van Putten, W.J., Rijneveld, A.W., Lowenberg, B., and Valk, P.J. (2010). Acquired mutations in the genes encoding IDH1 and IDH2 both are recurrent aberrations in acute myeloid leukemia: prevalence and prognostic value. Blood 116, 2122-2126. https://doi.org/10.1182/blood-2009-11-250878
- Abdel-Wahab, O., Gao, J., Adli, M., Dey, A., Trimarchi, T., Chung, Y.R., Kuscu, C., Hricik, T., Ndiaye-Lobry, D., Lafave, L.M., et al. (2013). Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo. J. Exp. Med. 210, 2641-2659. https://doi.org/10.1084/jem.20131141
- Arioka, Y., Watanabe, A., Saito, K., and Yamada, Y. (2012). Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins. PLos One 7, e45031. https://doi.org/10.1371/journal.pone.0045031
- Arita, K., Ariyoshi, M., Tochio, H., Nakamura, Y., and Shirakawa, M. (2008). Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism. Nature 455, 818-821. https://doi.org/10.1038/nature07249
- Avvakumov, G.V., Walker, J.R., Xue, S., Li, Y.J., Duan, S.L., Bronner, C., Arrowsmith, C.H., and Dhe-Paganon, S. (2008). Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1. Nature 455, 822-825. https://doi.org/10.1038/nature07273
- Bachman, M., Uribe-Lewis, S., Yang, X.P., Williams, M., Murrell, A., and Balasubramanian, S. (2014). 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem. 6, 1049-1055. https://doi.org/10.1038/nchem.2064
- Bachman, M., Uribe-Lewis, S., Yang, X.P., Burgess, H.E., Iurlaro, M., Reik, W., Murrell, A., and Balasubramanian, S. (2015). 5-Formylcytosine can be a stable DNA modification in mammals. Nat. Chem. Biol. 11, 555-557. https://doi.org/10.1038/nchembio.1848
- Blaschke, K., Ebata, K.T., Karimi, M.M., Zepeda-Martinez, J.A., Goyal, P., Mahapatra, S., Tam, A., Laird, D.J., Hirst, M., Rao, A., et al. (2013). Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature 500, 222-226. https://doi.org/10.1038/nature12362
- Bostick, M., Kim, J.K., Esteve, P.O., Clark, A., Pradhan, S., and Jacobsen, S.E. (2007). UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760-1764. https://doi.org/10.1126/science.1147939
- Busque, L., Patel, J.P., Figueroa, M.E., Vasanthakumar, A., Provost, S., Hamilou, Z., Mollica, L., Li, J., Viale, A., Heguy, A., et al. (2012). Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat. Genet. 44, 1179-1181. https://doi.org/10.1038/ng.2413
- Cairns, R.A., Iqbal, J., Lemonnier, F., Kucuk, C., de Leval, L., Jais, J.P., Parrens, M., Martin, A., Xerri, L., Brousset, P., et al. (2012). IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma. Blood 119, 1901-1903. https://doi.org/10.1182/blood-2011-11-391748
- Challen, G.A., Sun, D.Q., Jeong, M., Luo, M., Jelinek, J., Berg, J.S., Bock, C., Vasanthakumar, A., Gu, H.C., Xi, Y.X., et al. (2012). Dnmt3a is essential for hematopoietic stem cell differentiation. Nat. Genet. 44, 23-31. https://doi.org/10.1038/ng.1009
- Chang, Y.I., Damnernsawad, A., Allen, L.K., Yang, D., Ranheim, E.A., Young, K.H., Zhang, J.F., Kong, G.Y., Wang, J.Y., Liu, Y.G., et al. (2014). Evaluation of allelic strength of human TET2 mutations and cooperation between Tet2 knockdown and oncogenic Nras mutation. Br. J. Haematol. 166, 461-465. https://doi.org/10.1111/bjh.12871
- Chen, C.C., Wang, K.Y., and Shen, C.K. (2012). The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases. J. Biol. Chem. 287, 33116-33121. https://doi.org/10.1074/jbc.C112.406975
- Cheng, J.J., Guo, S.Q., Chen, S.N., Mastriano, S.J., Liu, C.C., D'Alessio, A.C., Hysolli, E., Guo, Y.W., Yao, H., Megyola, C.M., et al. (2013). An extensive network of TET2-targeting microRNAs regulates malignant hematopoiesis. Cell Rep. 5, 471-481. https://doi.org/10.1016/j.celrep.2013.08.050
- Chim, C.S., Wan, T.S., Fung, T.K., and Wong, K.F. (2010). Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms. J. Clin. Pathol. 63, 942-946. https://doi.org/10.1136/jcp.2010.080218
- Cimmino, L., Dawlaty, M.M., Ndiaye-Lobry, D., Yap, Y.S., Bakogianni, S., Yu, Y., Bhattacharyya, S., Shaknovich, R., Geng, H., Lobry, C., et al. (2015). TET1 is a tumor suppressor of hematopoietic malignancy. Nat. Immunol. 16, 653-662. https://doi.org/10.1038/ni.3148
- Couronne, L., Bastard, C., and Bernard, O.A. (2012). TET2 and DNMT3A mutations in human T-cell lymphoma. N Engl. J. Med. 366, 95-96. https://doi.org/10.1056/NEJMc1111708
- Dang, L., White, D.W., Gross, S., Bennett, B.D., Bittinger, M.A., Driggers, E.M., Fantin, V.R., Jang, H.G., Jin, S., Keenan, M.C., et al. (2009). Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744. https://doi.org/10.1038/nature08617
- De Vita, S., Schneider, R.K., Garcia, M., Wood, J., Gavillet, M., Ebert, B.L., Gerbaulet, A., Roers, A., Levine, R.L., Mullally, A., et al. (2014). Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis. PLoS One 9, e96209. https://doi.org/10.1371/journal.pone.0096209
- Delhommeau, F., Dupont, S., Della Valle, V., James, C., Trannoy, S., Masse, A., Kosmider, O., Le Couedic, J.P., Robert, F., Alberdi, A., et al. (2009). Mutation in TET2 in myeloid cancers. N Engl. J. Med. 360, 2289-2301. https://doi.org/10.1056/NEJMoa0810069
- Figueroa, M.E., Abdel-Wahab, O., Lu, C., Ward, P.S., Patel, J., Shih, A., Li, Y., Bhagwat, N., Vasanthakumar, A., Fernandez, H.F., et al. (2010). Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 18, 553-567. https://doi.org/10.1016/j.ccr.2010.11.015
- Fu, X.H., Jin, L., Wang, X.C., Luo, A., Hu, J.K., Zheng, X.W., Tsark, W.M., Riggs, A.D., Ku, H.T., and Huang, W.D. (2013). MicroRNA- 26a targets ten eleven translocation enzymes and is regulated during pancreatic cell differentiation. Proc. Natl. Acad. Sci. USA 110, 17892-17897. https://doi.org/10.1073/pnas.1317397110
- Gelsi-Boyer, V., Trouplin, V., Roquain, J., Adelaide, J., Carbuccia, N., Esterni, B., Finetti, P., Murati, A., Arnoulet, C., Zerazhi, H., et al. (2010). ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia. Br. J. Haematol. 151, 365-375. https://doi.org/10.1111/j.1365-2141.2010.08381.x
- Gross, S., Cairns, R.A., Minden, M.D., Driggers, E.M., Bittinger, M.A., Jang, H.G., Sasaki, M., Jin, S.F., Schenkein, D.P., Su, S.S.M., et al. (2010). Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations. J. Exp. Med. 207, 339-344. https://doi.org/10.1084/jem.20092506
- Guo, J.U., Su, Y.J., Zhong, C., Ming, G.L., and Song, H.J. (2011). Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434. https://doi.org/10.1016/j.cell.2011.03.022
- Haferlach, T., Nagata, Y., Grossmann, V., Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014). Landscape of genetic lesions in 944 patients with myelodysplastic syndromes. Leukemia 28, 241-247. https://doi.org/10.1038/leu.2013.336
- Hanssens, K., Brenet, F., Agopian, J., Georgin-Lavialle, S., Damaj, G., Cabaret, L., Chandesris, M.O., de Sepulveda, P., Hermine, O., Dubreuil, P., et al. (2014). SRSF2-p95 hotspot mutation is highly associated with advanced forms of mastocytosis and mutations in epigenetic regulator genes. Haematologica 99, 830-835. https://doi.org/10.3324/haematol.2013.095133
- Hashimoto, H., Horton, J.R., Zhang, X., Bostick, M., Jacobsen, S.E., and Cheng, X.D. (2008). The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix. Nature 455, 826-829. https://doi.org/10.1038/nature07280
- Hashimoto, H., Liu, Y., Upadhyay, A.K., Chang, Y., Howerton, S.B., Vertino, P.M., Zhang, X., and Cheng, X. (2012). Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 40, 4841-4849. https://doi.org/10.1093/nar/gks155
- Hashimoto, H., Zhang, X., and Cheng, X.D. (2013). Selective excision of 5-carboxylcytosine by a thymine DNA glycosylase mutant. J. Mol. Biol. 425, 971-976. https://doi.org/10.1016/j.jmb.2013.01.013
- Hashimoto, H., Olanrewaju, Y.O., Zheng, Y., Wilson, G.G., Zhang, X., and Cheng, X.D. (2014). Wilms tumor protein recognizes 5-carboxylcytosine within a specific DNA sequence. Genes Dev. 28, 2304-2313. https://doi.org/10.1101/gad.250746.114
- He, Y.F., Li, B.Z., Li, Z., Liu, P., Wang, Y., Tang, Q., Ding, J., Jia, Y., Chen, Z., Li, L., et al. (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307. https://doi.org/10.1126/science.1210944
- Hino, S., Kishida, S., Michiue, T., Fukui, A., Sakamoto, I., Takada, S., Asashima, M., and Kikuchi, A. (2001). Inhibition of the Wnt signaling pathway by Idax, a novel Dvl-binding protein. Mol. Cell Biol. 21, 330-342. https://doi.org/10.1128/MCB.21.1.330-342.2001
- Hon, G.C., Song, C.X., Du, T.T., Jin, F.L., Selvaraj, S., Lee, A.Y., Yen, C.A., Ye, Z., Mao, S.Q., Wang, B.A., et al. (2014). 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell 56, 286-297. https://doi.org/10.1016/j.molcel.2014.08.026
- Hu, L.L., Li, Z., Cheng, J.D., Rao, Q.H., Gong, W., Liu, M.J., Shi, Y.J.G., Zhu, J.Y., Wang, P., and Xu, Y.H. (2013). Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155, 1545-1555. https://doi.org/10.1016/j.cell.2013.11.020
- Huang, Y., and Rao, A. (2014). Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 30, 464-474. https://doi.org/10.1016/j.tig.2014.07.005
- Huang, Y., Pastor, W.A., Shen, Y.H., Tahiliani, M., Liu, D.R., and Rao, A. (2010). The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLos One 5, e8888. https://doi.org/10.1371/journal.pone.0008888
- Huang, H., Jiang, X., Li, Z., Li, Y., Song, C.X., He, C., Sun, M., Chen, P., Gurbuxani, S., Wang, J., et al. (2013). TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc. Natl. Acad. Sci. USA 110, 11994-11999. https://doi.org/10.1073/pnas.1310656110
- Huang, Y., Chavez, L., Chang, X., Wang, X., Pastor, W.A., Kang, J., Zepeda-Martinez, J.A., Pape, U.J., Jacobsen, S.E., Peters, B., et al. (2014). Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 111, 1361-1366. https://doi.org/10.1073/pnas.1322921111
- Ito, S., Shen, L., Dai, Q., Wu, S.C., Collins, L.B., Swenberg, J.A., He, C., and Zhang, Y. (2011). Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303. https://doi.org/10.1126/science.1210597
- Itzykson, R., Kosmider, O., Renneville, A., Morabito, M., Preudhomme, C., Berthon, C., Ades, L., Fenaux, P., Platzbecker, U., Gagey, O., et al. (2013). Clonal architecture of chronic myelomonocytic leukemias. Blood 121, 2186-2198. https://doi.org/10.1182/blood-2012-06-440347
- Iurlaro, M., Ficz, G., Oxley, D., Raiber, E.A., Bachman, M., Booth, M.J., Andrews, S., Balasubramanian, S., and Reik, W. (2013). A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 14, R119. https://doi.org/10.1186/gb-2013-14-10-r119
- Iyer, L.M., Tahiliani, M., Rao, A., and Aravind, L. (2009). Prediction of novel families of enzymes involved in oxidative and other complex modifications of bases in nucleic acids. Cell Cycle 8, 1698-1710. https://doi.org/10.4161/cc.8.11.8580
- Iyer, L.M., Abhiman, S., and Aravind, L. (2011). Natural history of eukaryotic DNA methylation systems. Prog. Mol. Biol. Transl. Sci. 101, 25-104. https://doi.org/10.1016/B978-0-12-387685-0.00002-0
- Kats, L.M., Reschke, M., Taulli, R., Pozdnyakova, O., Burgess, K., Bhargava, P., Straley, K., Karnik, R., Meissner, A., Small, D., et al. (2014). Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance. Cell Stem Cell 14, 329-341. https://doi.org/10.1016/j.stem.2013.12.016
- Kellinger, M.W., Song, C.X., Chong, J., Lu, X.Y., He, C., and Wang, D. (2012). 5-formylcytosine and 5-carboxylcytosine reduce the rate and substrate specificity of RNA polymerase II transcription. Nat. Struct. Mol. Biol. 19, 831-833. https://doi.org/10.1038/nsmb.2346
- Kim, Y.H., Pierscianek, D., Mittelbronn, M., Vital, A., Mariani, L., Hasselblatt, M., and Ohgaki, H. (2011). TET2 promoter methylation in low-grade diffuse gliomas lacking IDH1/2 mutations. J. Clin. Pathol. 64, 850-852. https://doi.org/10.1136/jclinpath-2011-200133
- Ko, M., Huang, Y., Jankowska, A.M., Pape, U.J., Tahiliani, M., Bandukwala, H.S., An, J., Lamperti, E.D., Koh, K.P., Ganetzky, R., et al. (2010). Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839-843. https://doi.org/10.1038/nature09586
- Ko, M., Bandukwala, H.S., An, J., Lamperti, E.D., Thompson, E.C., Hastie, R., Tsangaratou, A., Rajewsky, K., Koralov, S.B., and Rao, A. (2011). Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108, 14566-14571. https://doi.org/10.1073/pnas.1112317108
- Ko, M., An, J., Bandukwala, H.S., Chavez, L., Aijo, T., Pastor, W.A., Segal, M.F., Li, H.M., Koh, K.P., Lahdesmaki, H., et al. (2013). Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 497, 122-126. https://doi.org/10.1038/nature12052
- Ko, M., An, J., Pastor, W.A., Koralov, S.B., Rajewsky, K., and Rao, A. (2015). TET proteins and 5-methylcytosine oxidation in hematological cancers. Immunol. Rev. 263, 6-21. https://doi.org/10.1111/imr.12239
- Kojima, T., Shimazui, T., Hinotsu, S., Joraku, A., Oikawa, T., Kawai, K., Horie, R., Suzuki, H., Nagashima, R., Yoshikawa, K., et al. (2009). Decreased expression of CXXC4 promotes a malignant phenotype in renal cell carcinoma by activating Wnt signaling. Oncogene 28, 297-305. https://doi.org/10.1038/onc.2008.391
- Konstandin, N., Bultmann, S., Szwagierczak, A., Dufour, A., Ksienzyk, B., Schneider, F., Herold, T., Mulaw, M., Kakadia, P.M., Schneider, S., et al. (2011). Genomic 5-hydroxymethylcytosine levels correlate with TET2 mutations and a distinct global gene expression pattern in secondary acute myeloid leukemia. Leukemia 25, 1649-1652. https://doi.org/10.1038/leu.2011.134
- Kunimoto, H., Fukuchi, Y., Sakurai, M., Sadahira, K., Ikeda, Y., Okamoto, S., and Nakajima, H. (2012). Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells. Sci. Rep. 2, 273. https://doi.org/10.1038/srep00273
- Kunimoto, H., Fukuchi, Y., Sakurai, M., Takubo, K., Okamoto, S., and Nakajima, H. (2014). Tet2-mutated myeloid progenitors possess aberrant in vitro self-renewal capacity. Blood 123, 2897- 2899. https://doi.org/10.1182/blood-2014-01-552471
- Langemeijer, S.M.C., Kuiper, R.P., Berends, M., Knops, R., Aslanyan, M.G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A.G., Raymakers, R.A.P., et al. (2009). Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 41, 838-842. https://doi.org/10.1038/ng.391
- Lemonnier, F., Couronne, L., Parrens, M., Jais, J.P., Travert, M., Lamant, L., Tournillac, O., Rousset, T., Fabiani, B., Cairns, R.A., et al. (2012). Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with T-FH-like features and adverse clinical parameters. Blood 120, 1466-1469. https://doi.org/10.1182/blood-2012-02-408542
- Li, Z., Cai, X., Cai, C.L., Wang, J., Zhang, W., Petersen, B.E., Yang, F.C., and Xu, M. (2011). Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509-4518. https://doi.org/10.1182/blood-2010-12-325241
- Lorsbach, R.B., Moore, J., Mathew, S., Raimondi, S.C., Mukatira, S.T., and Downing, J.R. (2003). TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia 17, 637-641. https://doi.org/10.1038/sj.leu.2402834
- Lu, F.L., Liu, Y.T., Jiang, L., Yamaguchi, S., and Zhang, Y. (2014). Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 28, 2103-2119. https://doi.org/10.1101/gad.248005.114
- Maiti, A., and Drohat, A.C. (2011). Thymine DNA glycosylase can rapidly excise 5-formylcytosine and 5-carboxylcytosine: potential implications for active demethylation of CpG sites. J. Biol. Chem. 286, 35334-35338. https://doi.org/10.1074/jbc.C111.284620
- Meggendorfer, M., Roller, A., Haferlach, T., Eder, C., Dicker, F., Grossmann, V., Kohlmann, A., Alpermann, T., Yoshida, K., Ogawa, S., et al. (2012). SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML). Blood 120, 3080-3088. https://doi.org/10.1182/blood-2012-01-404863
- Minor, E.A., Court, B.L., Young, J.I., and Wang, G.F. (2013). Ascorbate Induces Ten-Eleven Translocation (Tet) Methylcytosine Dioxygenase-mediated Generation of 5-Hydroxymethylcytosine. J. Biol. Chem. 288, 13669-13674. https://doi.org/10.1074/jbc.C113.464800
- Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M.E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011). Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11-24. https://doi.org/10.1016/j.ccr.2011.06.001
- Muto, T., Sashida, G., Oshima, M., Wendt, G.R., Mochizuki-Kashio, M., Nagata, Y., Sanada, M., Miyagi, S., Saraya, A., Kamio, A., et al. (2013). Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders. J. Exp. Med. 210, 2627-2639. https://doi.org/10.1084/jem.20131144
- Nakagawa, T., Lv, L., Nakagawa, M., Yu, Y.B., Yu, C., D'Alessio, A.C., Nakayama, K., Fan, H.Y., Chen, X., and Xiong, Y. (2015). CRL4(VprBP) E3 Ligase Promotes Monoubiquitylation and Chromatin Binding of TET Dioxygenases. Mol. Cell 57, 247-260. https://doi.org/10.1016/j.molcel.2014.12.002
- Odejide, O., Weigert, O., Lane, A.A., Toscano, D., Lunning, M.A., Kopp, N., Kim, S., van Bodegom, D., Bolla, S., Schatz, J.H., et al. (2014). A targeted mutational landscape of angioimmunoblastic T-cell lymphoma. Blood 123, 1293-1296. https://doi.org/10.1182/blood-2013-10-531509
- Ono, R., Taki, T., Taketani, T., Taniwaki, M., Kobayashi, H., and Hayashi, Y. (2002). LCX, leukemia-associated protein with a CXXC domain, is fused to MLL in acute myeloid leukemia with trilineage dysplasia having t(10;11)(q22;q23). Cancer Res. 62, 4075-4080.
- Ooi, S.K.T., O'Donnell, A.H., and Bestor, T.H. (2009). Mammalian cytosine methylation at a glance. J. Cell Sci. 122, 2787-2791. https://doi.org/10.1242/jcs.015123
- Paez, D., Gerger, A., Zhang, W., Yang, D., Labonte, M.J., Benhanim, L., Kahn, M., Lenz, F., Lenz, C., Ning, Y., et al. (2014). Association of common gene variants in the WNT/beta-catenin pathway with colon cancer recurrence. Pharmacogenomics J. 14, 142-150. https://doi.org/10.1038/tpj.2013.20
- Palomero, T., Couronne, L., Khiabanian, H., Kim, M.Y., Ambesi- Impiombato, A., Perez-Garcia, A., Carpenter, Z., Abate, F., Allegretta, M., Haydu, J.E., et al. (2014). Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat. Genet. 46, 166-170. https://doi.org/10.1038/ng.2873
- Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C.J., Ellis, P., Wedge, D.C., Pellagatti, A., et al. (2013). Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122, 3616-3627. https://doi.org/10.1182/blood-2013-08-518886
- Parsons, D.W., Jones, S., Zhang, X.S., Lin, J.C.H., Leary, R.J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.M., Gallia, G.L., et al. (2008). An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812. https://doi.org/10.1126/science.1164382
- Pastor, W.A., Aravind, L., and Rao, A. (2013). TETonic shift: biological roles of TET proteins in DNA demethylation and transcription. Nat. Rev. Mol. Cell Biol. 14, 341-356. https://doi.org/10.1038/nrm3589
- Patel, J.P., Gonen, M., Figueroa, M.E., Fernandez, H., Sun, Z.X., Racevskis, J., Van Vlierberghe, P., Dolgalev, I., Thomas, S., Aminova, O., et al. (2012). Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl. J. Med. 366, 1079-1089. https://doi.org/10.1056/NEJMoa1112304
- Pronier, E., Almire, C., Mokrani, H., Vasanthakumar, A., Simon, A., Mor, B.D.R.M., Masse, A., Le Couedic, J.P., Pendino, F., Carbonne, B., et al. (2011). Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors. Blood 118, 2551-2555. https://doi.org/10.1182/blood-2010-12-324707
- Quivoron, C., Couronne, L., Della Valle, V., Lopez, C.K., Plo, I., Wagner-Ballon, O., Do Cruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.H., et al. (2011). TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 20, 25-38. https://doi.org/10.1016/j.ccr.2011.06.003
- Raiber, E.A., Murat, P., Chirgadze, D.Y., Beraldi, D., Luisi, B.F., and Balasubramanian, S. (2015). 5-Formylcytosine alters the structure of the DNA double helix. Nat. Struct. Mol. Biol. 22, 44-49. https://doi.org/10.1038/nsmb.2936
- Rampal, R., Alkalin, A., Madzo, J., Vasanthakumar, A., Pronier, E., Patel, J., Li, Y.S., Ahn, J.H., Abdel-Wahab, O., Shih, A., et al. (2014). DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep. 9, 1841-1855. https://doi.org/10.1016/j.celrep.2014.11.004
- Sakata-Yanagimoto, M., Enami, T., Yoshida, K., Shiraishi, Y., Ishii, R., Miyake, Y., Muto, H., Tsuyama, N., Sato-Otsubo, A., Okuno, Y., et al. (2014). Somatic RHOA mutation in angioimmunoblastic T cell lymphoma. Nat. Genet. 46, 171-175. https://doi.org/10.1038/ng.2872
- Sasaki, M., Knobbe, C.B., Munger, J.C., Lind, E.F., Brenner, D., Brustle, A., Harris, I.S., Holmes, R., Wakeham, A., Haight, J., et al. (2012). IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488, 656-659. https://doi.org/10.1038/nature11323
- Schiesser, S., Hackner, B., Pfaffeneder, T., Muller, M., Hagemeier, C., Truss, M., and Carell, T. (2012). Mechanism and stem-cell activity of 5-carboxycytosine decarboxylation determined by isotope tracing. Angew. Chem. Int. Ed. Engl. 51, 6516-6520. https://doi.org/10.1002/anie.201202583
- Sharif, J., Muto, M., Takebayashi, S.I., Suetake, I., Iwamatsu, A., Endo, T.A., Shinga, J., Mizutani-Koseki, Y., Toyoda, T., Okamura, K., et al. (2007). The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908-912. https://doi.org/10.1038/nature06397
- Shen, L., Song, C.X., He, C., and Zhang, Y. (2014). Mechanism and function of oxidative reversal of DNA and RNA methylation. Annu. Rev. Biochem. 83, 585-614. https://doi.org/10.1146/annurev-biochem-060713-035513
- Shide, K., Kameda, T., Shimoda, H., Yamaji, T., Abe, H., Kamiunten, A., Sekine, M., Hidaka, T., Katayose, K., Kubuki, Y., et al. (2012). TET2 is essential for survival and hematopoietic stem cell homeostasis. Leukemia 26, 2216-2223. https://doi.org/10.1038/leu.2012.94
- Shih, A.H., Jiang, Y.W., Meydan, C., Shank, K., Pandey, S., Barreyro, L., Antony-Debre, I., Viale, A., Socci, N., Sun, Y.M., et al. (2015). Mutational cooperativity linked to combinatorial epigenetic gain of function in acute myeloid leukemia. Cancer Cell 27, 502-515. https://doi.org/10.1016/j.ccell.2015.03.009
- Song, S.J., Ito, K., Ala, U., Kats, L., Webster, K., Sun, S.M., Jongen-Lavrencic, M., Manova-Todorova, K., Teruya-Feldstein, J., Avigan, D.E., et al. (2013a). The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell selfrenewal and transformation. Cell Stem Cell 13, 87-101. https://doi.org/10.1016/j.stem.2013.06.003
- Song, S.J., Poliseno, L., Song, M.S., Ala, U., Webster, K., Ng, C., Beringer, G., Brikbak, N.J., Yuan, X., Cantley, L.C., et al. (2013b). MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154, 311-324. https://doi.org/10.1016/j.cell.2013.06.026
- Spruijt, C.G., Gnerlich, F., Smits, A.H., Pfaffeneder, T., Jansen, P.W., Bauer, C., Munzel, M., Wagner, M., Muller, M., Khan, F., et al. (2013). Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 152, 1146-1159. https://doi.org/10.1016/j.cell.2013.02.004
- Sun, M., Song, C.X., Huang, H., Frankenberger, C.A., Sankarasharma, D., Gomes, S., Chen, P., Chen, J.J., Chada, K.K., He, C., et al. (2013). HMGA2/TET1/HOXA9 signaling pathway regulates breast cancer growth and metastasis. Proc. Natl. Acad. Sci. USA 110, 9920-9925. https://doi.org/10.1073/pnas.1305172110
- Suzuki, M.M., and Bird, A. (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat. Rev. Genet. 9, 465-476.
- Tahiliani, M., Koh, K.P., Shen, Y., Pastor, W.A., Bandukwala, H., Brudno, Y., Agarwal, S., Iyer, L.M., Liu, D.R., Aravind, L., et al. (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935. https://doi.org/10.1126/science.1170116
- Tefferi, A., Levine, R.L., Lim, K.H., Abdel-Wahab, O., Lasho, T.L., Patel, J., Finke, C.M., Mullally, A., Li, C.Y., Pardanani, A., et al. (2009). Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia 23, 900-904. https://doi.org/10.1038/leu.2009.37
- Thol, F., Weissinger, E.M., Krauter, J., Wagner, K., Damm, F., Wichmann, M., Gohring, G., Schumann, C., Bug, G., Ottmann, O., et al. (2010). IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis. Haematologica 95, 1668-1674. https://doi.org/10.3324/haematol.2010.025494
- Traina, F., Visconte, V., Jankowska, A.M., Makishima, H., O'Keefe, C.L., Elson, P., Han, Y.C., Hsieh, F.H., Sekeres, M.A., Mali, R.S., et al. (2012). Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosis. PLos One 7, e43090. https://doi.org/10.1371/journal.pone.0043090
- Valinluck, V., and Sowers, L.C. (2007). Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67, 946-950. https://doi.org/10.1158/0008-5472.CAN-06-3123
- Viguie, F., Aboura, A., Bouscary, D., Ramond, S., Delmer, A., Tachdjian, G., Marie, J.P., and Casadevall, N. (2005). Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement? Leukemia 19, 1411-1415. https://doi.org/10.1038/sj.leu.2403818
- Wang, Y., and Zhang, Y. (2014). Regulation of TET protein stability by Calpains. Cell Rep. 6, 278-284. https://doi.org/10.1016/j.celrep.2013.12.031
- Wang, L.F., Zhou, Y., Xu, L., Xiao, R., Lu, X.Y., Chen, L., Chong, J., Li, H.R., He, C., Fu, X.D., et al. (2015a). Molecular basis for 5- carboxycytosine recognition by RNA polymerase II elongation complex. Nature 523, 621-625. https://doi.org/10.1038/nature14482
- Wang, Y.P., Xiao, M.T., Chen, X.F., Chen, L.L., Xu, Y.P., Lv, L., Wang, P., Yang, H., Ma, S.H., Lin, H.P., et al. (2015b). WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Mol. Cell 57, 662-673. https://doi.org/10.1016/j.molcel.2014.12.023
- Ward, P.S., Patel, J., Wise, D.R., Abdel-Wahab, O., Bennett, B.D., Coller, H.A., Cross, J.R., Fantin, V.R., Hedvat, C.V., Perl, A.E., et al. (2010). The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234. https://doi.org/10.1016/j.ccr.2010.01.020
- Wu, H., and Zhang, Y. (2014). Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156, 45-68. https://doi.org/10.1016/j.cell.2013.12.019
- Xu, W., Yang, H., Liu, Y., Yang, Y., Wang, P., Kim, S.H., Ito, S., Yang, C., Wang, P., Xiao, M.T., et al. (2011a). Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer Cell 19, 17-30. https://doi.org/10.1016/j.ccr.2010.12.014
- Xu, Y.F., Wu, F.Z., Tan, L., Kong, L.C., Xiong, L.J., Deng, J., Barbera, A.J., Zheng, L.J., Zhang, H.K., Huang, S., et al. (2011b). Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42, 451-464. https://doi.org/10.1016/j.molcel.2011.04.005
- Xu, Y.F., Xu, C., Kato, A., Tempel, W., Abreu, J.G., Bian, C.B., Hu, Y.G., Hu, D., Zhao, B., Cerovina, T., et al. (2012). Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 151, 1200-1213. https://doi.org/10.1016/j.cell.2012.11.014
- Yan, H., Parsons, D.W., Jin, G.L., McLendon, R., Rasheed, B.A., Yuan, W.S., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G.J., et al. (2009). IDH1 and IDH2 Mutations in Gliomas. N Engl. J. Med. 360, 765-773. https://doi.org/10.1056/NEJMoa0808710
- Yin, R., Mao, S.Q., Zhao, B., Chong, Z., Yang, Y., Zhao, C., Zhang, D., Huang, H., Gao, J., Li, Z., et al. (2013). Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc. 135, 10396-10403. https://doi.org/10.1021/ja4028346
- Zhang, H.K., Zhang, X., Clark, E., Mulcahey, M., Huang, S., and Shi, Y.G. (2010). TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 20, 1390-1393. https://doi.org/10.1038/cr.2010.156
- Zhang, L., Lu, X., Lu, J., Liang, H., Dai, Q., Xu, G.L., Luo, C., Jiang, H., and He, C. (2012). Thymine DNA glycosylase specifically recognizes 5-carboxylcytosine-modified DNA. Nat. Chem. Biol. 8, 328-330. https://doi.org/10.1038/nchembio.914
-
Zhang, Q., Liu, X.G., Gao, W.Q., Li, P.S., Hou, J.L., Li, J.W., and Wong, J.M. (2014). Differential regulation of the ten-eleven translocation (TET) family of dioxygenases by O-linked
$\beta$ -N-acetylglucosamine transferase (OGT). J. Biol. Chem. 289, 5986-5996. https://doi.org/10.1074/jbc.M113.524140 - Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015). Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389-393. https://doi.org/10.1038/nature15252
Cited by
- Modeling Myeloid Malignancies Using Zebrafish vol.7, pp.2234-943X, 2017, https://doi.org/10.3389/fonc.2017.00297
- New hope: the emerging role of 5-hydroxymethylcytosine in mental health and disease vol.8, pp.7, 2015, https://doi.org/10.2217/epi-2016-0020
- DNA Demethylation of the Foxp3 Enhancer Is Maintained through Modulation of Ten-Eleven-Translocation and DNA Methyltransferases vol.39, pp.12, 2015, https://doi.org/10.14348/molcells.2016.0276
- Tumor necrosis factor-α decreases EC-SOD expression through DNA methylation vol.60, pp.3, 2015, https://doi.org/10.3164/jcbn.16-111
- TET family dioxygenases and DNA demethylation in stem cells and cancers vol.49, pp.4, 2015, https://doi.org/10.1038/emm.2017.5
- Gene-body hypermethylation controlled cryptic promoter and miR26A1-dependent EZH2 regulation of TET1 gene activity in chronic lymphocytic leukemia vol.8, pp.44, 2017, https://doi.org/10.18632/oncotarget.20668
- Inhibition of DNA methyltransferase leads to increased genomic 5‐hydroxymethylcytosine levels in hematopoietic cells vol.8, pp.4, 2015, https://doi.org/10.1002/2211-5463.12392
- Epigenetic Effects of the 13 Vitamins vol.4, pp.6, 2015, https://doi.org/10.1007/s40495-018-0161-2
- Inhibitors of DNA Methylation and Histone Deacetylation as Epigenetically Active Drugs for Anticancer Therapy vol.25, pp.6, 2015, https://doi.org/10.2174/1381612825666190405144026
- Advances in detection and quantification of methylcytosine and its derivatives vol.42, pp.5, 2015, https://doi.org/10.1002/jssc.201801100
- Epigenetic Dysregulation at the Crossroad of Women’s Cancer vol.11, pp.8, 2015, https://doi.org/10.3390/cancers11081193
- Function determinants of TET proteins: the arrangements of sequence motifs with specific codes vol.20, pp.5, 2015, https://doi.org/10.1093/bib/bby053
- Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia vol.12, pp.None, 2019, https://doi.org/10.1186/s13072-018-0252-7